7-45003002-G-A

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBS1_SupportingBS2

The NM_031443.4(CCM2):​c.30+2639G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00183 in 152,328 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as not provided (no stars).

Frequency

Genomes: 𝑓 0.0018 ( 1 hom., cov: 31)

Consequence

CCM2
NM_031443.4 intron

Scores

2

Clinical Significance

not provided no classification provided O:1

Conservation

PhyloP100: -0.0520

Publications

0 publications found
Variant links:
Genes affected
CCM2 (HGNC:21708): (CCM2 scaffold protein) This gene encodes a scaffold protein that functions in the stress-activated p38 Mitogen-activated protein kinase (MAPK) signaling cascade. The protein interacts with SMAD specific E3 ubiquitin protein ligase 1 (also known as SMURF1) via a phosphotyrosine binding domain to promote RhoA degradation. The protein is required for normal cytoskeletal structure, cell-cell interactions, and lumen formation in endothelial cells. Mutations in this gene result in cerebral cavernous malformations. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Nov 2009]
CCM2 Gene-Disease associations (from GenCC):
  • cerebral cavernous malformation 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • famililal cerebral cavernous malformations
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00183 (278/152328) while in subpopulation NFE AF = 0.00243 (165/68026). AF 95% confidence interval is 0.00212. There are 1 homozygotes in GnomAd4. There are 142 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High AC in GnomAd4 at 278 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_031443.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CCM2
NM_031443.4
MANE Select
c.30+2639G>A
intron
N/ANP_113631.1
CCM2
NM_001363458.2
c.30+2639G>A
intron
N/ANP_001350387.1
CCM2
NM_001363459.2
c.30+2639G>A
intron
N/ANP_001350388.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CCM2
ENST00000258781.11
TSL:1 MANE Select
c.30+2639G>A
intron
N/AENSP00000258781.7
CCM2
ENST00000541586.5
TSL:3
c.30+2639G>A
intron
N/AENSP00000444725.1
CCM2
ENST00000544363.5
TSL:3
c.30+2639G>A
intron
N/AENSP00000438035.1

Frequencies

GnomAD3 genomes
AF:
0.00183
AC:
278
AN:
152210
Hom.:
1
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.000169
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000982
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00829
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00243
Gnomad OTH
AF:
0.00143
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.00183
AC:
278
AN:
152328
Hom.:
1
Cov.:
31
AF XY:
0.00191
AC XY:
142
AN XY:
74490
show subpopulations
African (AFR)
AF:
0.000168
AC:
7
AN:
41582
American (AMR)
AF:
0.000981
AC:
15
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4832
European-Finnish (FIN)
AF:
0.00829
AC:
88
AN:
10614
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00243
AC:
165
AN:
68026
Other (OTH)
AF:
0.00142
AC:
3
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
16
33
49
66
82
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00307
Hom.:
0
Bravo
AF:
0.00116
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

ClinVar submissions as Germline

Significance:not provided
Revision:no classification provided
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
-
Cerebral cavernous malformation 2 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
1.4
DANN
Benign
0.67
PhyloP100
-0.052
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs181735976; hg19: chr7-45042601; API